Level Chart

Basic Info

Becton Dickinson and Co (BDX) - Urology and Critical Care Revenue is at a current level of 365.00M, up from 355.00M last quarter and up from 333.00M one year ago. This is a change of 2.82% from last quarter and 9.61% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 365.00M
Latest Period Dec 2023
Last Updated Apr 30 2024, 08:41 EDT
Next Release Jul 31 2024, 08:30 EDT (E)
Average Growth Rate 6.22%
Value from Last Quarter 355.00M
Change from Last Quarter 2.82%
Value from 1 Year Ago 333.00M
Change from 1 Year Ago 9.61%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
December 31, 2023 365.00M
September 30, 2023 355.00M
June 30, 2023 349.00M
March 31, 2023 336.00M
December 31, 2022 333.00M
September 30, 2022 318.00M
June 30, 2022 326.00M
March 31, 2022 320.00M
December 31, 2021 340.00M
Date Value
September 30, 2021 306.00M
June 30, 2021 310.00M
March 31, 2021 298.00M
December 31, 2020 317.00M
September 30, 2020 293.00M
June 30, 2020 268.00M
March 31, 2020 279.00M
December 31, 2019 291.00M

Basic Info

Becton Dickinson and Co (BDX) - Urology and Critical Care Revenue is at a current level of 365.00M, up from 355.00M last quarter and up from 333.00M one year ago. This is a change of 2.82% from last quarter and 9.61% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 365.00M
Latest Period Dec 2023
Last Updated Apr 30 2024, 08:41 EDT
Next Release Jul 31 2024, 08:30 EDT (E)
Average Growth Rate 6.22%
Value from Last Quarter 355.00M
Change from Last Quarter 2.82%
Value from 1 Year Ago 333.00M
Change from 1 Year Ago 9.61%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
BDX Becton Dickinson & Co 2.87%